U.S. is Blacklisting 34 Chinese Biotech Companies. (But they missed one)

The United States on Dec. 16 slapped trade and investment restrictions on dozens of Chinese entities over their role in weaponizing biotechnology and other U.S. innovations to bolster the Chinese military and to further its human rights abuses.

Among the 34 Chinese entities targeted was the Academy of Military Medical Sciences—China’s top medical research institute run by the Chinese military—alongside its 11 research institutes, for aiding the Chinese military with biotechnology, including “purported brain-control weaponry,” the department stated without elaborating on the technology.

In 2018, the Academy of Military Medical Sciences applied for a patent for technology for collecting and processing brain signals, according to an online patent repository.

The Institute of Radiation and Radiation Medicine, one of its subsidiaries that were targeted, published a Chinese paper in 2012 discussing how to establish a data bank on the behavioral effects of “mind control assault weapons.”

Trade restrictions were also imposed on HMN Technologies, formerly a company under Chinese telecom provider Huawei as Huawei Marine, as well as Jiangsu Hengtong OpticElectric, Shanghai Aoshi Control Technology Co., and Zhongtian Technology Submarine Cable, for their role in acquiring U.S. items to modernize the Chinese military.

These bodies were put on the “entity list,” which bars U.S. companies from doing business with the sanctioned entity without a special license.

“The scientific pursuit of biotechnology and medical innovation can save lives. Unfortunately, the PRC [People’s Republic of China] is choosing to use these technologies to pursue control over its people and its repression of members of ethnic and religious minority groups,” Secretary of Commerce Gina Raimondo said in a Dec. 16 statement.

“We cannot allow U.S. commodities, technologies, and software that support medical science and biotechnical innovation to be diverted toward uses contrary to U.S. national security.”

The trade restrictions followed a U.S. investment ban last week on Chinese artificial intelligence firm SenseTime, after it was discovered that its subsidiary had developed a facial recognition program targeting ethnic Uyghurs in Xinjiang, where Beijing is conducting an expansive campaign of repression.

The Treasury Department separately on Thursday banned American investment into eight Chinese tech firms: Cloudwalk Technology Co., Ltd.; Dawning Information Industry Co., Ltd.; Leon Technology Company Limited; Megvii Technology Limited; Netposa Technologies Limited; SZ DJI Technology Co., Ltd.; Xiamen Meiya Pico Information Co., Ltd.; and Yitu Limited. It accused them of supporting Beijing in the biometric surveillance and tracking of Uyghur Muslims and other religious minorities in China.

Guangzhou-based software developer Cloudwalk Technology, the Treasury Department said, has designed a facial recognition software to track ethnic minority groups such as Tibetans and Uyghurs, and alert authorities of any large gathering in a particular location. The company has also made a pact with the Zimbabwean government to build a mass surveillance network in the country, which would source images from the network to improve the software’s recognition of skin pigmentation.

Meiya Pico, a digital data forensics firm based in China’s coastal province of Fujian, has developed a mobile application to extract images, location data, audio, and messages from residents’ cell phones, according to a report by the Australian Strategic Policy Institute (ASPI). The company also helped create a tool to transcribe and translate the Uyghur language, enabling Xinjiang authorities to screen locals’ devices for offensive content.

In 2018, officials ordered Xinjiang residents to install Meiya’s surveillance software on their desktop to monitor their activities, the Treasury Department said. The ASPI report also found Meiya Pico to have provided training to Interpol and sold mobile hacking gear to the Russian military.

All eight companies are already on the Commerce Department’s entity list.

Most of the 37 entities under the Commerce Department ban on Thursday are based in China. A network of entities from China, as well as Georgia, Malaysia, and Turkey were also added to the trade blacklist for “diverting or attempting to divert U.S. items to Iran’s military programs,” according to the Commerce Department.

As part of this package, Commerce added eight entities for facilitating the export of U.S. items to Iran in violation of the Export Administration Regulations (EAR) or to entities on the U.S. Department of the Treasury’s Office of Foreign Assets Control Specially-Designated Nationals List. Commerce added another six entities for their involvement in the procurement of U.S.-origin electronic components, likely in furtherance of Russian military programs. Additionally, Commerce added one entity to the Military End-User List under the destination of Russia. Finally, Commerce removed one entity from the Unverified List, as a conforming change to this same entity being added to the Entity List for being involved in proliferation to unsafeguarded nuclear activities.

Commerce.gov

HMN Technologies, one of the sanctioned Chinese firms, was sold by Huawei to a Shanghai-listed company in 2019, shortly after Huawei was itself put on the entity list. The move was aimed to free Huawei’s undersea cable business from U.S restrictions, analysts said at the time.

Washington has been sounding alarms over Chinese-built undersea cables because of concerns that they could be used by Beijing for espionage and to sabotage global communications. A World Bank-led project to build a cable connecting three Pacific Island nations was reportedly scrapped in June after the United States warned that HMN Technologies’ involvement in the project created a security threat.

A leaked report obtained by The Epoch Times in 2018 shows that the Chinese regime might be intercepting communications from undersea cables, creating a risk for all phone and internet data transferred through networks in the Asia-Pacific region.

While the U.S government is taking precautions to ensure national security is prioritized in these crazy times, they can’t get every threat. FF Gene Biotech (or Fulgent Genetics) is still selling it’s COVID-19 testing equipment in the United States and sending its DNA sequencing data to China. The risks associated with this data in the hands of the Chinese Communist Party have already been detailed in a previous article. Essentially, if the CCP has access to millions of American’s DNA sequencing data, a targeted bioweapon attack against people with specific traits could be carried out. With this kind of data collection in the works already, one has to assume China is either currently working on a way to target individuals with a bioweapon, or already has the capability to do so.

With that in mind, is it possible that there are democrats in American government that are bought and paid for by Klaus Schwab? His convenient ‘Great Reset’ occurred at the perfect time for all of these politicians to fall in line and adhere to his globalist guidelines. If you’ve convinced yourself that there is not a hidden narrative in all of these moving pieces in world politics, you’re in absolute denial. Because the American people have been systematically programmed to see conspiracy theories as a joke. When in reality, most of the truth is often stranger than fiction. Stay inquisitive in the word of God, and the world around you.

Source: EpochTimes

FF Gene Biotech is a next generation DNA sequencing company in China and was founded by Fulgent Genetics which is a primary distributor of COVID-19 tests nationwide. As of January 12, 2021, LA county announced it’s intent on relying on Fulgent Genetics to provide covid tests moving forward. Little does America know, FF Gene Biotech has set up shop in China to conduct cutting edge research on next generation DNA sequencing.

The official relationship between the two companies is briefly explained on their site as follows:

FF Gene Biotech formed in 2017 through a Joint Venture between Fulgent Genetics, Xilong Scientific, and Fuzhou Jinqiang Investment Partnership (FJIP). The company was founded to bring Fulgent Genetics’ next-generation sequencing (NGS) capabilities to the Chinese genetic testing market. On May 10th, 2021, Fulgent Genetics acquired a majority stake in FF Gene Biotech. The terms of the transaction were not disclosed.

What do improvements in DNA sequencing mean for human health?

Researchers now are able to compare large stretches of DNA – 1 million bases or more – from different individuals quickly and cheaply. Such comparisons can yield an enormous amount of information about the role of inheritance in susceptibility to disease and in response to environmental influences. In addition, the ability to sequence the genome more rapidly and cost-effectively creates vast potential for diagnostics and therapies.

Although routine DNA sequencing in the doctor’s office is still many years away, some large medical centers have begun to use sequencing to detect and treat some diseases. In cancer, for example, physicians are increasingly able to use sequence data to identify the particular type of cancer a patient has. This enables the physician to make better choices for treatments.

Researchers in the NHGRI-supported Undiagnosed Diseases Program use DNA sequencing to try to identify the genetic causes of rare diseases. Other researchers are studying its use in screening newborns for disease and disease risk.

Moreover, The Cancer Genome Atlas project, which is supported by NHGRI and the National Cancer Institute, is using DNA sequencing to unravel the genomic details of some 30 cancer types. Another National Institutes of Health program examines how gene activity is controlled in different tissues and the role of gene regulation in disease. Ongoing and planned large-scale projects use DNA sequencing to examine the development of common and complex diseases, such as heart disease and diabetes, and in inherited diseases that cause physical malformations, developmental delay and metabolic diseases.

Comparing the genome sequences of different types of animals and organisms, such as chimpanzees and yeast, can also provide insights into the biology of development and evolution.

LA Sheriff Resigns Due to Fulgent Genetics CCP Ties

Founded by Chinese-American billionaire Ming Hsieh, Fulgent Genetics seems to be quite a popular COVID-19 testing provider for the United States. Los Angeles County sheriff Alex Villanueva said the FBI warned him and other county officials that Fulgent likely shares the health data it collects with the Chinese government.

“This letter is to inform you the Los Angeles County Sheriff’s Department (Department) will not participate in COVID-19 registering or testing with Fulgent Genetics Corporation (Fulgent), due to the fact the DNA data obtained is not guaranteed to be safe and secure from foreign governments and ‘will likely be shared with the Republic of China,’” Villanueva wrote in the letter.

The sheriff said he was contacted by the Federal Bureau of Investigation’s (FBI) weapons of mass destruction coordinator about Fulgent Genetics and met with the coordinator on Nov. 26.

Villaneuva said he was shocked to learn that the company had strong ties with BGI, WuXP, and Huawei Technology, all of which are linked to the Chinese Academy of Medical Sciences and the Peoples Republic of China State Council, which are under the control of the CCP.

Rep. Ted Lieu (D-Los Angeles) asked Fulgent Genetics on Twitter on Nov. 30 about its privacy statement that declares the company may store, process, and transmit personal information in locations around the world, including locations outside of the country.

The no-bid contract signed between the county and Fulgent Genetics allows them to collect DNA data obtained from mandatory COVID-19 testing, for unknown purposes, Villanueva said. This has shattered all confidence the department’s personnel had in the process, he said.

U.S. officials have expressed concerns over state-sponsored harvesting of genetic data. China has collected DNA samples of Uyghurs, a repressed Muslim minority group, for surveillance purposes. The authoritarian regime is also building massive databases of genetic data from across the globe, which would give China an advantage in developing treatments for future pandemics.

A New Era of Biowarfare

Biowarfare isn’t a new thing; its been used throughout history. In the 4th century B.C., Scythian archers infected their arrows by dipping them in decomposed carcasses. In the 14th century, the Tartars catapulted plague-infected lifeless bodies into the lines of their enemies at the siege of Kaffa. And in World War II, the Imperial Japanese Army bombed Chinese cities with plague-ridden fleas.

This old school form of biological warfare is child’s play in comparison to modern advances in artificial intelligence (AI) and genomics. We are entering a new and dangerous era in warfare, and we’re supposed to believe that this is a natural pandemic. Anyone who actually cares to absorb knowledge wouldn’t rule out the possibility that modern advances in science could potentially lead us to biological warfare.

We have to understand that if someone has a copy of your DNA sequence, they have a copy of all individual characteristics. AI and genomics enable DNA manipulation to help the human body fight all kinds of diseases, this same technology can also be used to create unique pathogens that only impact specific people. DNA-specific weapons can target a race, a gender, or even a family or individual with a specific DNA structure.

Anyone advocating for vaccinations is coming from a naive perspective and takes no interest in international politics. Knowing this has helped me know when it’s not worth the energy to elaborate on my views. The reality is this, the CCP is looking for more and more power. Undeniably, America is weakened in light of political tension and vaccine efficacy debate.

Fulgent provides coronavirus testing for numerous school districts, including New York City and Las Vegas, and has contracts with the Utah Department of Health and the Houston Health Department. The company has blatant ties to the CCP, especially considering you can’t run a business in China without accomplishing the tasks of the CCP. It all adds up to an elaborate display of global biological warfare. Stay inquisitive in the word of God, and the world around you.